Answers are grounded in this paper and cite their sources.
Validation study demonstrates the utility of a screening tool for neuropathic components in low back pain, indicating its value for guiding targeted therapy.
Simple, patient-based, easy-to-use screening questionnaires can determine the prevalence of neuropathic pain components both in individual LBP patients and in heterogeneous cohorts of such patients. Since NeP correlates with more intense pain, more severe co-morbidity and poorer quality of life, accurate diagnosis is a milestone in choosing appropriate therapy.
No takes yet. Share an insight, caveat, or question.
Freynhagen et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: